HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Phosphate restriction reduces proteinuria of the uninephrectomized, diabetic rat.

Abstract
Proteinuria is the clinical hallmark of diabetic nephropathy and the harbinger of progressive renal disease. Therefore, the present study was designed to examine the effect of phosphate restriction on the proteinuria of streptozotocin-induced diabetes mellitus in the rat. Uninephrectomy was performed in experimental and control groups to worsen the degree of diabetic nephropathy. Proteinuria was prevented in Sprague-Dawley rats treated with the intestinal phosphate binder, dihydroxyaluminum aminoacetate (DHAAA) (24.75 +/- 20.35 mg/d at 3 months v control, 77.45 +/- 44.72 mg/d, P less than 0.001); an effect that was independent of protein and caloric intake, plasma albumin and lipids, severity of diabetes, mean arterial pressures, cardiac output, and renal calcium accumulation. The effect of DHAAA on protein excretion and glomerular hemodynamics was examined in similarly prepared Munich-Wistar rats; these rats did not tolerate long-term studies. Three weeks of DHAAA again caused a consistent fall in proteinuria (5.98 +/- 7.28 v 34.94 +/- 24.28 mg/d) and in transmembrane hydraulic pressure difference (41.1 +/- 1.2 v 46.4 +/- 2.8 mm Hg, P less than 0.005). In conclusion, phosphate restriction significantly decreases the proteinuria of Sprague-Dawley and Munich-Wistar uninephrectomized rats with streptozotocin-induced diabetes mellitus. Micropuncture of Munich-Wistar rats suggests that a reduction of intraglomerular pressure may be at least partially responsible for such an effect.
AuthorsD C Harris, S A Falk, J D Conger, W S Hammond, R W Schrier
JournalAmerican journal of kidney diseases : the official journal of the National Kidney Foundation (Am J Kidney Dis) Vol. 11 Issue 6 Pg. 489-98 (Jun 1988) ISSN: 0272-6386 [Print] United States
PMID3376933 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Phosphates
  • Aluminum Hydroxide
  • dihydroxyaluminum aminoacetate
  • Glycine
Topics
  • Aluminum Hydroxide (administration & dosage)
  • Animals
  • Blood Pressure
  • Cardiac Output
  • Diabetes Mellitus, Experimental (physiopathology, urine)
  • Glomerular Filtration Rate
  • Glycine (administration & dosage, analogs & derivatives)
  • Male
  • Nephrectomy
  • Phosphates (deficiency)
  • Proteinuria
  • Rats
  • Rats, Inbred Strains
  • Renal Circulation
  • Vascular Resistance

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: